We found that CD133-high BC was significantly associated with higher expression levels of CSC marker genes: CD24, NOTCH1, DLL1, and ALDH1A1, consistently in both TCGA and METABRIC cohorts (all p < 0.001, Fig. 2A). This evidence concerns the gene ALDH1A1 and breast cancer.